Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis

References

• Alkhouri N, Tamimi TAR, Yerian L, Lopez R, Zein NN, Feldstein AE. 2010. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci. 55(9):2644–2650.
   PubMed Web of Science ®Google Scholar
• Allard JB, Rinaldi L, Wargo MJ, Allen G, Akira S, Uematsu S, Poynter ME, Hogan DA, Rincon M, Whittaker LA. 2009. Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products. Eur J Immunol. 39(3):776–788.
   PubMed Web of Science ®Google Scholar
• Azevedo MDS, Marques H, Binelli LS, Malange MSV, Devides AC, Silva EA, Fachin LRV, Ghidella CC, Soares CT, Garlet GP, et al. 2017. Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events. Med Microbiol Immunol. 206(6):429–439.
   PubMed Web of Science ®Google Scholar
• Baskol M, Seckin KD, Baskol G. 2015. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with NASH. Turk J Gastroenterol. 25(1):32–37.
   Google Scholar
• Boland ML, Oldham S, Boland BB, Will S, Lapointe JM, Guionaud S, Rhodes CJ, Trevaskis JL. 2018. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction. World J Gastroenterol. 24(16):1748–1765.
   PubMed Web of Science ®Google Scholar
• Bouteau A, Kervevan J, Su QT, Zurawski SM, Contreras V, Dereuddre-Bosquet N, Le Grand R, Zurawski G, Cardinaud S, Levy Y, et al. 2019. Dc subsets regulate humoral immune responses by supporting the differentiation of distinct Tfh cells. Front Immunol. 10:1134.
   PubMed Web of Science ®Google Scholar
• Carrier P, Debette-Gratien M, Girard M, Jacques J, Nubukpo P, Loustaud-Ratti V. 2016. Liver illness and psychiatric patients. Hepat Mon. 16(12):e41564.
   PubMed Web of Science ®Google Scholar
• Chavez-Tapia NC, Rosso N, Tiribelli C. 2012. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol. 12:20.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wei J, Zhu J, Liu W, Cui J, Li H, Chen F. 2016. Chm-1 gene-modified bone marrow mesenchymal stem cells maintain the chondrogenic phenotype of tissue-engineered cartilage. Stem Cell Res Ther. 7(1):70.
   PubMedGoogle Scholar
• Cheng CW, Tan J, Qian W, Zhang L, Hou XH. 2018. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: attention to the gut-vascular barrier dysfunction. Life Sci. 209:157–166.
   PubMed Web of Science ®Google Scholar
• Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. 2011. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 54(1):133–144.
   PubMed Web of Science ®Google Scholar
• Cui Y, Wang Q, Chang R, Zhou X, Xu C. 2019. Intestinal barrier function-non-alcoholic fatty liver disease interactions and possible role of gut microbiota. J Agric Food Chem. 67(10):2754–2762.
   PubMed Web of Science ®Google Scholar
• Derakhshesh N, Salamat N, Movahedinia A, Hashemitabar M, Bayati V. 2019. Exposure of liver cell culture from the orange-spotted grouper, Epinephelus coioides, to benzo(a)pyrene and light results in oxidative damage as measured by antioxidant enzymes. Chemosphere. 226:534–544.
   PubMed Web of Science ®Google Scholar
• Du Plessis J, Korf H, van Pelt J, Windmolders P, Vander Elst I, Verrijken A, Hubens G, Van Gaal L, Cassiman D, Nevens F, et al. 2016. Pro-inflammatory cytokines but not endotoxin-related parameters associate with disease severity in patients with NAFLD. PLOS One. 11(12):e0166048.
   PubMed Web of Science ®Google Scholar
• Gabele E, Dostert K, Hofmann C, Wiest R, Scholmerich J, Hellerbrand C, Obermeier F. 2011. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol. 55(6):1391–1399.
   PubMed Web of Science ®Google Scholar
• Hu QL, Jiang QY, Jin X, Shen J, Wang K, Li YB, Xu FJ, Tang GP, Li ZH. 2013. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials. 34(9):2265–2276.
   PubMed Web of Science ®Google Scholar
• Hwang J. 2017. Effects of MOK, a pharmacopuncture medicine, on the TH1/TH2 immune response and antioxidation in Con A-stimulated primary mouse splenocytes. Acupuncture. 34(2):39–48.
   Google Scholar
• Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol. 175(7):4320–4330.
   PubMed Web of Science ®Google Scholar
• Ji J, Ramos-Vicente D, Navas-Perez E, Herrera-Ubeda C, Lizcano JM, Garcia-Fernandez J, Escriva H, Bayes A, Roher N. 2018. Characterization of the TLR family in Branchiostoma lanceolatum and discovery of a novel TLR22-Like involved in dsRNA recognition in amphioxus. Front Immunol. 9:15.
   PubMed Web of Science ®Google Scholar
• Krysko DV, Mussche S, Leybaert L, D'Herde L. 2004. Gap junctional communication and connexin43 expression in relation to apoptotic cell death and survival of granulosa cells. J Histochem Cytochem. 52(9):1199–1207.
   PubMed Web of Science ®Google Scholar
• Lo ST, Orr DW, Barlett A, Gane EJ. 2015. Non-alcoholic fatty liver disease (NALFD) and hepatocellular carcinoma (HCC), clinical characteristics and outcome: a single centre experience. Hepatology. 62:1292A.
   Web of Science ®Google Scholar
• Lombardi R, Onali S, Thorburn D, Davidson BR, Gurusamy KS, Tsochatzis E. 2017. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis. Cochrane Database Syst Rev. (3):CD011640.
   PubMedGoogle Scholar
• Ma J, Ning YN, Xu M, Hou Y, Wang N, Hou XY, Yu YY, Li H, He WD, Shao LL, et al. 2013. Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia. Blood. 122(12):2074–2082.
   PubMed Web of Science ®Google Scholar
• Mastrangeli G, Corinti S, Butteroni C, Afferni C, Bonura A, Boirivant M, Colombo P, Di Felice G. 2009. Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol. 150(2):133–143.
   PubMed Web of Science ®Google Scholar
• Mbongue JC, Nieves HA, Torrez TW, Langridge WHR. 2017. The role of dendritic cell maturation in the induction of insulin-dependent diabetes mellitus. Front Immunol. 8:327.
   PubMed Web of Science ®Google Scholar
• Nguyen TTN, Kim YM, Kim TD, Le OTT, Kim JJ, Kang HC, Hasegawa H, Kanaho Y, Jou I, Lee SY. 2013. Phosphatidylinositol 4-phosphate 5-kinase α facilitates toll-like receptor 4-mediated microglial inflammation through regulation of the toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location. J Biol Chem. 288(8):5645–5659.
   PubMed Web of Science ®Google Scholar
• Ore A, Akinloye OA. 2019. Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease. Medicina. 55:13.
   PubMedGoogle Scholar
• Pan Q, Zhang Q, Chu J, Pais R, Liu SS, He C, Eko FO. 2017. Chlamydia abortus Pmp18.1 induces IL-1 beta secretion by TLR4 activation through the MyD88, NF-kappa B, and caspase-1 signaling pathways. Front Cell Infect Microbiol. 7:16.
   PubMed Web of Science ®Google Scholar
• Patel KD, Abeysekera KWM, Marlais M, McPhail MJW, Thomas HC, Fitzpatrick JA, Lim AKP, Taylor-Robinson SD, Thomas EL. 2011. Recent advances in imaging hepatic fibrosis and steatosis. Expert Rev Gastroenterol Hepatol. 5(1):91–104.
   PubMed Web of Science ®Google Scholar
• Paulovicova L, Paulovicova E, Karelin AA, Tsvetkov YE, Nifantiev NE, Bystricky S. 2015. Immune cell response to Candida cell wall mannan derived branched α-oligomannoside conjugates in mice. J Microbiol Immunol Infect. 48(1):9–19.
   PubMedGoogle Scholar
• Reichold A, Brenner S, Spruss A, Rings A, Forster-Fromme K, Bergheim I, Bischoff SC. 2012. Oral Bifidobacterium adolescentis supplementation attenuates nonalcoholic steatohepatitis (NASH) in a mouse model. J Hepatol. 56:S497–S498.
   Web of Science ®Google Scholar
• Seeley JJ, Ghosh S. 2017. Molecular mechanisms of innate memory and tolerance to LPS. J Leukoc Biol. 101(1):107–119.
   PubMed Web of Science ®Google Scholar
• Shi N, Na L, Xinwang D, Haitao N. 2017. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 4:14.
   PubMed Web of Science ®Google Scholar
• Song H-Y, Zhang L, Pan J-L, Yang L-L, Ji G. 2013. Corrigendum: bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. J Integr Med. 11(4):262–268.
   PubMedGoogle Scholar
• Sugimura T, Jounai K, Ohshio K, Tanaka T, Suwa M, Fujiwara D. 2013. Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells. J Clin Immunol. 149(3):509–518.
   Google Scholar
• Thome R, Moore JN, Mari ER, Rasouli J, Hwang D, Yoshimura S, Ciric B, Zhang GX, Rostami AM. 2017. Induction of peripheral tolerance in ongoing autoimmune inflammation requires interleukin 27 signaling in dendritic cells. Front Immunol. 8:1392.
   PubMed Web of Science ®Google Scholar
• Turner MS, Isse K, Fischer DK, Turnquist HR, Morel PA. 2014. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes. Diabetologia. 57(7):1428–1436.
   PubMed Web of Science ®Google Scholar
• Wang M, Sun S, Wu T, Zhang L, Song H, Hao W, Zheng P, Xing L, Ji G. 2013. Inhibition of LXRα/SREBP-1c-mediated hepatic steatosis by Jiang-Zhi Granule. Evid Based Complement Alternat Med. 2013:584634.
   PubMed Web of Science ®Google Scholar
• Wang YC, Kong WZ, Jin QM, Chen J, Dong L. 2015. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World J Gastroenterol. 21(35):10104–10112.
   PubMed Web of Science ®Google Scholar
• Xie WQ, Ge M, Li GX, Zhang LN, Tang ZQ, Li RY, Zhang RL. 2017. Astragalus polysaccharide protect against cadmium-induced cytotoxicity through the MDA5/NF-kappa B pathway in chicken peripheral blood lymphocytes. Molecules. 22(10):1610.
   PubMed Web of Science ®Google Scholar
• Yao AH, Jia LY, Zhang YK, Ma QR, Cheng P, Liu L, Ju G, Kuang F. 2012. Early blockade of TLRs MyD88-dependent pathway may reduce secondary spinal cord injury in the rats. Evid Based Complement Alternat Med. 2012:591298.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. 2018. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 15(1):11–20.
   PubMed Web of Science ®Google Scholar
• Yu SJ, Kim W, Kim D, Yoon J-H, Lee K, Kim JH, Cho EJ, Lee J-H, Kim HY, Kim YJ, et al. 2015. Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease. Medicine. 94(48):e2159.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wong YT, Tang KY, Kwan HY, Su, T. 2020. Chinese medicinal herbs targeting the gut–liver axis and adipose tissue–liver axis for non-alcoholic fatty liver disease treatments: the ancient wisdom and modern science. Front Endocrinol (Lausanne). 11:572729.
   PubMed Web of Science ®Google Scholar
• Zheng YY, Wang M, Shu XB, Zheng PY, Ji G. 2018a. Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury. World J Gastroenterol. 24(9):992–1003.
   PubMed Web of Science ®Google Scholar
• Zheng YY, Wang M, Zheng PY, Tang XD, Ji G. 2018b. Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease. Sci Rep. 8(1):13681.
   PubMedGoogle Scholar
• Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, Ghaffari SM, Abdirad A. 2013. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food Chem Toxicol. 58:198–209.
   PubMed Web of Science ®Google Scholar
• Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS. 2005. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 73(5):2940–2950.
   PubMed Web of Science ®Google Scholar